Lara Longpre, CHIEF DEVELOPMENT OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 1,003 shares at $20.62 ($21K) on 2023-01-09, disclosed to the SEC on 2024-03-18.
Open-market sale of $21k MIRM by CHIEF DEVELOPMENT OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MIRM | SELL | 2023-07-05 | $26K | — | Filing → |
| MIRM | SELL | 2021-10-01 | $19K | — | Filing → |